
Thrombin-based topical haemostatic agent effective for TKR revision surgery

Thrombin-based topical haemostatic agent effective for TKR revision surgery
Does a thrombin-based topical haemostatic agent reduce blood loss and transfusion requirements after total knee revision surgery? A randomized, controlled trial
Knee Surg Sports Traumatol Arthrosc. 2015 Nov;23(11):3337-42Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
48 patients undergoing total knee replacement (TKR) revision surgery were randomly assigned to either receive or not receive a thrombin-based topical haemostatic agent (Floseal haemostatic matrix) for the management of postoperative blood loss. The purpose of this study was to compare the effect of Floseal on blood loss and the need for blood transfusion to a control group over the first 7 postope...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Join the Conversation
Please Login or Join to leave comments.